Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-06-30 View official record Methodology

Covered recipient · General Payments record

NANCI ADINOLFI

Physician Assistants & Advanced Practice Nursing Providers Physician Assistant

NPI
1083810766
CMS profile
10769185
Location
MERCED, CA

General Payments · PY2022–2025

$1,406.01

  • Reported across 27 records
  • CMS publication 2026-06-30

Latest program year · PY2025

$617.19

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2025 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $617.19 14

By paying entity

PY2025 · sorted by reported total

Paying entityAmountRecords
Bayer HealthCare Pharmaceuticals Inc. $226.53 2
Acerta Pharma LLC $188.01 3
Axsome Therapeutics, Inc. $143.61 8
Corcept Therapeutics $59.04 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2022 $145.45 4
PY2023 $124.99 1
PY2024 $518.38 8
PY2025 $617.19 14

Payment records · PY2025 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2025 202220232024 Record-level detail is published for PY2025; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $9.76 01/29/2025 Food and Beverage Undisputed 06/30/2026 1206212599 CMS
AstraZeneca Pharmaceuticals LP $67.07 07/17/2025 Food and Beverage Undisputed 06/30/2026 1206206986 CMS
AstraZeneca Pharmaceuticals LP $111.18 11/06/2025 Food and Beverage Undisputed 06/30/2026 1207264259 CMS
Axsome Therapeutics, Inc. $11.74 04/04/2025 Food and Beverage Undisputed 06/30/2026 1235654605 CMS
Axsome Therapeutics, Inc. $10.15 04/04/2025 Food and Beverage Undisputed 06/30/2026 1235654654 CMS
Axsome Therapeutics, Inc. $2.40 06/09/2025 Food and Beverage Undisputed 06/30/2026 1235741505 CMS
Axsome Therapeutics, Inc. $5.00 06/09/2025 Food and Beverage Undisputed 06/30/2026 1235741535 CMS
Axsome Therapeutics, Inc. $7.88 07/14/2025 Food and Beverage Undisputed 06/30/2026 1235400755 CMS
Axsome Therapeutics, Inc. $8.00 07/14/2025 Food and Beverage Undisputed 06/30/2026 1235400875 CMS
Axsome Therapeutics, Inc. $12.33 07/16/2025 Food and Beverage Undisputed 06/30/2026 1235400952 CMS
Axsome Therapeutics, Inc. $86.11 07/22/2025 Food and Beverage Undisputed 06/30/2026 1235763631 CMS
Bayer Healthcare Pharmaceuticals Inc. $105.18 02/14/2025 Food and Beverage Undisputed 06/30/2026 1225437740 CMS
Bayer Healthcare Pharmaceuticals Inc. $121.35 10/24/2025 Food and Beverage Undisputed 06/30/2026 1225437742 CMS
Corcept Therapeutics $59.04 02/26/2025 Food and Beverage Undisputed 06/30/2026 1214218305 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2022, 2023, 2024, 2025
Source files
Dataset page · Bulk file · PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.